Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Urinary hydroxyproline excretion in myelofibrosis

J C Wang, M K Aung, M S Tobin

    Blood
    |March 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Improved measurement of the form factors in the decay lambda+c-->lambda + nue.

    Physical review letters·2005
    Same author

    Relativistic electromagnetic ion cyclotron instabilities.

    Physical review. E, Statistical, nonlinear, and soft matter physics·2005
    Same author

    Search for the lepton-flavor-violating leptonic B(0)-->mu(+/-)tau(-/+) and B(0)-->e(+/-)tau(-/+).

    Physical review letters·2005
    Same author

    Study of the semileptonic charm decays D(0)-->pi(-)l(+)nu and D(0)-->K(-)l(+)nu.

    Physical review letters·2005
    Same author

    Measurement of the muonic branching fractions of the narrow upsilon resonances.

    Physical review letters·2005
    Same author

    Observation of 1(-)0(-) final states from psi(2S) decays and e(+)e(-) annihilation.

    Physical review letters·2005
    Same journal

    Decentralized Clinical Trials in Hematology: the Promise and the Peril.

    Blood·2026
    Same journal

    How I Treat Chemotherapy-Induced Thrombocytopenia with Thrombopoietin Receptor Agonists.

    Blood·2026
    Same journal

    The Chaos of Choice in Large B-cell Lymphoma: A Call to Harmonize First-line Trial Design.

    Blood·2026
    Same journal

    Precision Transfusion Medicine in the Omics Era.

    Blood·2026
    Same journal

    Fibrocytes drive JAK2V617F-mutated myelofibrosis: pitavastatin reverses marrow fibrosis and anemia.

    Blood·2026
    Same journal

    Identifying steroid-refractory aGVHD before it happens.

    Blood·2026
    See all related articles

    Urinary hydroxyproline levels can indicate bone marrow metastasis in cancer patients. Elevated hydroxyproline suggests marrow fibrosis and metastasis, aiding in diagnosis.

    Area of Science:

    • Biochemistry
    • Oncology
    • Hematology

    Background:

    • Hydroxyproline is a key component of collagen.
    • Elevated urinary hydroxyproline can indicate increased collagen turnover.
    • Bone marrow involvement in cancer and myelofibrosis affects collagen metabolism.

    Purpose of the Study:

    • To investigate urinary hydroxyproline levels in patients with cancer and myelofibrosis.
    • To determine if hydroxyproline excretion can differentiate between metastatic and non-metastatic bone marrow involvement.
    • To explore the diagnostic potential of hydroxyproline measurements in myelofibrosis.

    Main Methods:

    • Measurement of urinary hydroxyproline levels.
    • Comparison between healthy volunteers, cancer patients with and without bone marrow metastasis, and patients with myelofibrosis.

    Related Experiment Videos

  • Analysis of hydroxyproline excretion in relation to metastatic involvement and marrow fibrosis.

    • Main Results:

    • Patients without bone marrow metastasis showed normal hydroxyproline levels, similar to controls.
    • Elevated urinary hydroxyproline levels were observed in patients with bone marrow metastasis.
    • The highest hydroxyproline excretions were found in patients with both marrow metastasis and fibrosis.
    • Agnogenic myeloid metaplasia patients had hydroxyproline levels comparable to the control group.

    Conclusions:

    • Urinary hydroxyproline levels differ based on the presence and type of bone marrow involvement.
    • Hydroxyproline measurement may serve as a biomarker for bone marrow metastasis and fibrosis.
    • This technique could help distinguish between different types of myelofibrosis and aid in diagnosis.